E T Ruijter
About
In The Last Decade
E T Ruijter
14 papers receiving 997 citations
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 532
- Radiology, Nuclear Medicine and Imaging 402
- Molecular Biology 342
- Oncology 162
- Rheumatology 109
Countries citing papers authored by E T Ruijter
This map shows the geographic impact of E T Ruijter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E T Ruijter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E T Ruijter more than expected).
Fields of papers citing papers by E T Ruijter
This network shows the impact of papers produced by E T Ruijter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E T Ruijter. The network helps show where E T Ruijter may publish in the future.
Co-authorship network of co-authors of E T Ruijter
This figure shows the co-authorship network connecting the top 25 collaborators of E T Ruijter. A scholar is included among the top collaborators of E T Ruijter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E T Ruijter. E T Ruijter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | Molecular changes associated with prostate cancer development. | 5 |
| 3 | Cadherin switching in human prostate cancer progression. | 340 |
| 4 | 3 | |
| 5 | 32 | |
| 6 | Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group. | 36 |
| 7 | 1 | |
| 8 | Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma. | 27 |
| 9 | 31 | |
| 10 | 188 | |
| 11 | In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. | 112 |
| 12 | 6 | |
| 13 | 194 | |
| 14 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.